| scholarly article | Q13442814 |
| P2093 | author name string | Junjie Lu | |
| Hui Ding | |||
| Yi Shan | |||
| Yongfei Tan | |||
| Zhijun Ge | |||
| P2860 | cites work | Identification and characterization of genes differentially expressed in meningiomas | Q24311823 |
| Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data | Q33421674 | ||
| Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer | Q34415433 | ||
| Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis | Q34585318 | ||
| Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis | Q36171124 | ||
| Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis. | Q37006185 | ||
| Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis | Q37142251 | ||
| Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion | Q37619567 | ||
| Diagnostic molecular biomarkers for malignant pleural effusions. | Q37889963 | ||
| Clinical features and survival of lung cancer patients with pleural effusions | Q38364297 | ||
| The diagnosis of pleural effusions | Q38602583 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract | Q40514272 | ||
| Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer | Q43891642 | ||
| The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy | Q45847985 | ||
| Overexpression of MAC30 is Resistant to Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. | Q51594627 | ||
| Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers | Q57767697 | ||
| Diagnostic Utility of Serum and Pleural Fluid Carcinoembryonic Antigen, Neuron-Specific Enolase, and Cytokeratin 19 Fragments in Patients With Effusions From Primary Lung Cancer | Q58198360 | ||
| Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions | Q59274557 | ||
| Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion | Q73186410 | ||
| Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions | Q73405871 | ||
| Overexpression of MAC30 in the Cytoplasm of Oral Squamous Cell Carcinoma Predicts Nodal Metastasis and Poor Differentiation | Q82463053 | ||
| P433 | issue | 68 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| P304 | page(s) | 112809-112815 | |
| P577 | publication date | 2017-11-22 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion | |
| P478 | volume | 8 |
Search more.